Multi-Parametric Magnetic Resonance Imaging to Rule-In and Rule-Out Clinically Important Prostate Cancer in Men at Risk: A Cohort Study

Publisher： Karger

E-ISSN： 1423-0399|87|1|49-53

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.87, Iss.1, 2011-06, pp. : 49-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer

By  

CANCER, Vol. 120, Iss. 18, 2014-09 ,pp. : 2876-2882

John Wiley & Sons Inc

Access to resources Recommend Favorite

Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3359-3366

John Wiley & Sons Inc

Access to resources Recommend Favorite

In‐parallel comparative evaluation between multiparametric magnetic resonance imaging, prostate cancer antigen 3 and the prostate health index in predicting pathologically confirmed significant prostate cancer in men eligible for active surveillance

By  

BJU INTERNATIONAL, Vol. 118, Iss. 4, 2016-10 ,pp. : 527-534

John Wiley & Sons Inc

Access to resources Recommend Favorite

A urologists’ guide to the multi‐parametric magnetic resonance imaging (mpMRI)‐galaxy

By  

BJU INTERNATIONAL, Vol. 115, Iss. 4, 2015-04 ,pp. : 503-504

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS Criteria

By  

Urologia Internationalis, Vol. 96, Iss. 4, 2016-04 ,pp. : 459-469

Karger

Access to resources Recommend Favorite